The Cunningham Panel™ is designed to determine the level of autoimmune antibodies associated with neuropsychiatric disorders and their ability to stimulate and trigger neurological behavior. An increase in the level of these antibodies indicates that the symptoms present in the child may be related to an autoimmune reaction caused by the infection.
The Cunningham panel enables the practitioner to identify the presence of infections, and therefore to treat these infections, rather than treat the existing condition as a mental illness.
The Cunningham panel is a series of specialized blood tests that help clinicians diagnose infection-induced autoimmune neuropsychiatric syndromes, such as basal ganglia encephalitis and PANS/PANDAS.
RANDAS – Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal infection (pediatric autoimmune neuropsychiatric disorder associated with streptococcal infection) is a syndrome that combines all neuropsychiatric symptoms in children with proven autoimmune infection.
PANS - Pediatric Acute-onset Neuropsychiatric Syndrome (pediatric acute-onset neuropsychiatric syndrome) is a syndrome that is also characterized by neuropsychiatric disorders in children, but in this case, causes that are usually not specifically related to streptococcus, but may include more than 200 different factors, including other bacteria, viruses or even tumors.